| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 07/18/2006 | US7078407 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them |
| 07/18/2006 | US7078404 Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/13/2006 | WO2006074025A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 07/13/2006 | WO2005112945A3 Synthesis of tetracyclines and analogues thereof |
| 07/13/2006 | US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria, |
| 07/13/2006 | US20060154933 Inhibitors of Cdc25 phosphatases |
| 07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 07/13/2006 | CA2596393A1 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions |
| 07/13/2006 | CA2592900A1 Nitrogen containing bicyclic compounds and therapeutical use thereof |
| 07/12/2006 | EP1678180A1 Substituted 2h- 1,2,4 triazolo 4,3-a pyrazines as gsk-3 inhibitors |
| 07/12/2006 | EP1678167A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 07/12/2006 | EP1678154A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 07/12/2006 | EP1678142A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms |
| 07/12/2006 | CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses |
| 07/11/2006 | US7074534 Polymeric charge transport compositions and electronic devices made with such compositions |
| 07/11/2006 | CA2257204C Processes for producing phenoxy propionic acid derivatives |
| 07/11/2006 | CA2168447C Compounds and methods for inhibition of hiv and related viruses |
| 07/11/2006 | CA2123731C Process for the preparation of carboxamides of nitrogen-containing aromatic heterocyclic compounds and their use |
| 07/06/2006 | WO2006071759A2 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006055578A3 Asymmetric synthesis of (-)-agelastatin a |
| 07/06/2006 | WO2005108347A3 Substituted enaminones, their derivatives and uses thereof |
| 07/06/2006 | US20060149062 Sulfanyl substituted phenyl methanones |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148821 N,N-disubstituted diazocycloalkanes |
| 07/06/2006 | US20060148811 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
| 07/06/2006 | US20060148734 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds |
| 07/06/2006 | CA2592021A1 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| 07/05/2006 | EP1676855A2 Prenyl transferase inhibitors |
| 07/05/2006 | EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 07/05/2006 | EP1675835A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 07/05/2006 | CN1798742A Novel biaromatic compounds which activate ppar [upsilon] pharmaceutical compsns |
| 07/05/2006 | CN1798729A Benzamide nitrile derivatives |
| 07/04/2006 | US7071231 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/04/2006 | US7071214 Compounds and compositions for delivering active agents |
| 07/04/2006 | US7071196 Piperazine derivatives as antagonists of tachykinins, including substance P and other neurokinins. |
| 07/04/2006 | US7071180 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 07/04/2006 | CA2250840C Antivirally active heterocyclic azahexane derivatives |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006067466A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 06/29/2006 | WO2006067462A1 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 06/29/2006 | US20060142581 N-[4-(4-{2-[bis-((2S,3R)-2,3,4-trihydroxybutyl)amino]ethylamino}phenyl)butyl]-N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidine trihydrochloride; treating chronic bronchitis, cystic fibrosis, ventilator-induced pneumonia, asthma, chronic obstructive pulmonary disease, pneumonia and emphysema |
| 06/29/2006 | US20060142580 N-phenyl-2-pyrimidine-amine derivatives |
| 06/29/2006 | US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents |
| 06/29/2006 | CA2592092A1 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/29/2006 | CA2591827A1 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 06/29/2006 | CA2591208A1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | US7067501 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 06/22/2006 | WO2006021884A3 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 06/22/2006 | US20060135770 PARP inhibitors |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/22/2006 | US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/22/2006 | US20060135523 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| 06/22/2006 | US20060135487 Piperazine derivatives and their use as anti-inflammatory agents |
| 06/21/2006 | EP1670794A2 Vanilloid receptor ligands and their use in treatments |
| 06/21/2006 | EP1670774A1 Quinoxaline compounds |
| 06/21/2006 | EP1670763A1 Cyclopentene compounds |
| 06/21/2006 | EP1670756A1 Heterocyclyl compounds |
| 06/21/2006 | EP1670475A2 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 06/21/2006 | EP1670474A2 Cyclic pyrazinoylguanidine sodium channel blockers |
| 06/21/2006 | EP1670314A2 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1305047B1 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 06/21/2006 | EP1255734B1 Isatine derivatives with neurotrophic activity |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791592A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1791395A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1789263A Substituted piperazidine-piperidine amide compound, preparation method and uses thereof |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7064129 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life |
| 06/20/2006 | CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 06/15/2006 | WO2006061415A1 2,4 (4,6) pyrimidine derivatives |
| 06/15/2006 | WO2006061332A1 Gleevec process |
| 06/15/2006 | WO2006061215A2 2-alkyl-cycloalk(en)yl-carboxamides |
| 06/15/2006 | WO2006061193A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 06/15/2006 | WO2006061135A1 Phenyl-piperazin methanone derivatives |
| 06/15/2006 | WO2005058843A8 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/15/2006 | US20060128937 Diamine having quinoxaline unit, polyimide precursor, polyimide and use thereof |
| 06/15/2006 | US20060128903 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/15/2006 | CA2590220A1 2-alkyl-cycloalk(en)yl-carboxamides |
| 06/15/2006 | CA2589831A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 06/15/2006 | CA2589192A1 Phenyl-piperazin methanone derivatives |
| 06/15/2006 | CA2588761A1 2,4(4,6)pyrimidine derivatives |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |